---
title: "Zalando Shares Fall 7% After BaFin Opens Review of 2025 Financial Statements"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290978438.md"
description: "Zalando shares dropped 7% after Germany's BaFin launched a formal review of its 2025 financial statements. The probe concerns Zalando's €1.2 billion acquisition of ABOUT YOU, with regulators citing potential omissions in related-party transaction disclosures. BaFin clarified the review does not imply wrongdoing. Zalando described the matter as purely formal and insignificant, asserting that all takeover details were properly disclosed during the July 2025 process."
datetime: "2026-06-26T14:05:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290978438.md)
  - [en](https://longbridge.com/en/news/290978438.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290978438.md)
---

# Zalando Shares Fall 7% After BaFin Opens Review of 2025 Financial Statements

Zalando shares fell about 7% on June 26 after Germany’s financial regulator BaFin opened a formal review of the company’s 2025 financial statements. According to BeInCrypto, the probe is linked to Zalando’s 2025 acquisition of German online fashion retailer ABOUT YOU for about €1.2 billion, with BaFin citing signs the company may have omitted required related-party transaction information in its financial notes. BaFin said the review does not imply wrongdoing and auditors will publish results once complete. Zalando called the issue “purely formal and materially insignificant,” saying it is in close dialogue with BaFin and that takeover details were disclosed during the process completed in July 2025.

### Related Stocks

- [YOU.DE](https://longbridge.com/en/quote/YOU.DE.md)
- [ZAL.DE](https://longbridge.com/en/quote/ZAL.DE.md)

## Related News & Research

- [Zalando says BaFin reviews 2025 financial statements note, sees no KPI impact](https://longbridge.com/en/news/290924962.md)
- [Zalando says BaFin flags missing related-party disclosure in 2025 annual report annex, no financial impact](https://longbridge.com/en/news/293285185.md)
- [REG - Hospital Co.Dartford - Temporary Suspension](https://longbridge.com/en/news/294651479.md)
- [Fresenius says FDA, EMA accept Vedolizumab biosimilar PB016 filings for review](https://longbridge.com/en/news/294463337.md)
- [Wendel H1 2026 net income attributable to group turns to profit at EUR 69.5 million; net sales rise 3.2% to EUR 3.84 billion](https://longbridge.com/en/news/294303531.md)